Goldman Sachs
CLMT icon

Goldman Sachs’s Calumet Specialty Products CLMT Stock Holding History

Goldman Sachs’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,200
Closed -$869K – 6613
2026
Q1 		$869K Buy
+24,200
New +$627K ﹤0.01% 5190
2018
Q2 		– Sell
-12,200
Closed -$86K – 5693
2018
Q1 		$86K Sell
12,200
-26,000
-68% -$192K ﹤0.01% 5329
2017
Q4 		$294K Sell
38,200
-94,200
-71% -$785K ﹤0.01% 5187
2017
Q3 		$1.11M Buy
132,400
+115,100
+665% +$717K ﹤0.01% 4489
2017
Q2 		$74K Buy
17,300
+1,400
+9% +$5.62K ﹤0.01% 6241
2017
Q1 		$60K Sell
15,900
-11,800
-43% -$46.7K ﹤0.01% 6238
2016
Q4 		$111K Sell
27,700
-33,400
-55% -$136K ﹤0.01% 6091
2016
Q3 		$276K Buy
61,100
+14,600
+31% +$75.1K ﹤0.01% 5544
2016
Q2 		$228K Buy
46,500
+30,400
+189% +$172K ﹤0.01% 5593
2016
Q1 		$189K Buy
16,100
+3,300
+26% +$45.9K ﹤0.01% 5661
2015
Q4 		$255K Buy
12,800
+4,300
+51% +$106K ﹤0.01% 5494
2015
Q3 		$206K Sell
8,500
-3,800
-31% -$98.7K ﹤0.01% 5999
2015
Q2 		$313K Buy
12,300
+1,100
+10% +$29.2K ﹤0.01% 5693
2015
Q1 		$269K Buy
11,200
+5,600
+100% +$142K ﹤0.01% 5744
2014
Q4 		$125K Buy
5,600
+3,900
+229% +$101K ﹤0.01% 6471
2014
Q3 		$47K Sell
1,700
-3,100
-65% -$93.7K ﹤0.01% 6833
2014
Q2 		$153K Sell
4,800
-10,800
-69% -$321K ﹤0.01% 6378
2014
Q1 		$403K Buy
15,600
+7,800
+100% +$213K ﹤0.01% 5469
2013
Q4 		$203K Buy
7,800
+3,200
+70% +$89.4K ﹤0.01% 5951
2013
Q3 		$126K Buy
4,600
+3,300
+254% +$104K ﹤0.01% 6086
2013
Q2 		$47K Buy
+1,300
New +$46.7K ﹤0.01% 6065

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs's CLMT Position: Q2 2026 in Review

Goldman Sachs reduced its Calumet Specialty Products (CLMT) stake by 4.1% in Q2 2026, selling an estimated $556K and leaving 385,555 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2975.

Goldman Sachs first reported a position in CLMT in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.4M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Goldman Sachs held 385,555 shares of Calumet Specialty Products worth $13.9M as of Q2 2026.
  • Goldman Sachs sold 16,534 Calumet Specialty Products shares in Q2 2026, an estimated $556K.
  • Calumet Specialty Products made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2975 holding.
  • Goldman Sachs first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Calumet Specialty Products position peaked at $14.4M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.